RD

Ravikant Dineshprasad Singh

Active Director Designated Partner DIN 10919401
DIN 10919401 First appointment Jan 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Ravikant Dineshprasad Singh

Data last updated:

Ravikant Dineshprasad Singh is a Designated Partner at Medorus Healthcare Llp (since 2025).

DIN 10919401
Primary Designation Designated Partner
First Appointment 23 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner23 Jan 20252025Active

Board colleagues of Ravikant Dineshprasad Singh

NameDINCompanyDesignation
Sahil Rajesh Dagdiya07348769Medorus Healthcare LlpDesignated Partner
Vinod Shriramji Dagdiya01520472Medorus Healthcare LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Medorus Healthcare Llp
Premium access

Shareholding and investment profile for Ravikant Dineshprasad Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravikant Dineshprasad Singh

Ravikant Dineshprasad Singh currently holds 1 directorship: Medorus Healthcare Llp (Designated Partner, since 23 Jan 2025).

Ravikant Dineshprasad Singh was first appointed on 23 Jan 2025 as Designated Partner at Medorus Healthcare Llp.

The current boards of Ravikant Dineshprasad Singh's companies include Sahil Rajesh Dagdiya (Medorus Healthcare Llp), Vinod Shriramji Dagdiya (Medorus Healthcare Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available